FDA Clearance Tracker · P190002-S039
CAP24 Paddle Lead, Passing Elevator, Evoke CLS (REF 3042), Clarity Programming Application (CPA), and RECAP Viewer
Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jun 29, 2026
Approved
Time to decision
454 days
Received Apr 1, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P190002-S039
- Device name
- CAP24 Paddle Lead, Passing Elevator, Evoke CLS (REF 3042), Clarity Programming Application (CPA), and RECAP Viewer
- Applicant
- Saluda Medical Pty, Ltd.
- Applicant location
- Atarmon
- Received
- Apr 1, 2025
- Decided
- Jun 29, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P190002
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the CAP24 Paddle Lead and Passing Elevator components, software updates to the Clarity Clinical Programming Application (CPA) and RECAP Viewer (CDV) to support the CAP24 Paddle Lead and include minor bug fixes and improvements, and labeling updates to support these changes. Software changes required for use of the paddle lead with the Evoke Spinal Cord Stimulation (SCS) System were also approved in P190002/S038.
Source documents
Other decisions for Saluda Medical Pty, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Saluda Medical Evoke® SCS SystemPMA supplement
P190002-S019 · Decided Mar 20, 2024 · 180 days after receipt · Panel Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.